Protagonist Therapeutics Inc — Quarterly Financial Statistics (NASDAQ:PTGX) | MetaTrader

Open full chart

Financials

Overview Relatórios Statistics Dividends

Quarterly Annual

Cash from operating activities -27.86 M-29.18 M125.36 M-28.78 M-1.94 M-36.98 M 57.67 M Cash from investing activities 208.71 M8.72 M94.4 M-54.81 M58.55 M-48.81 M 49.33 M Cash from financing activities 12.05 M4.03 M11.44 M2.92 M5.66 M2.84 M 22.86 M Free cash flow -28.64 M-29.49 M124.82 M-29.59 M-2.02 M-37.12 M 56.08 M

Notícias

Protagonist Therapeutics earnings missed by $0.35, revenue fell short of estimates

Citizens eleva preço-alvo de Protagonist Therapeutics após aprovações de medicamentos

Citizens raises Protagonist Therapeutics stock price target on drug approvals

Diretor da Protagonist Therapeutics vende US$ 1,48 milhão em ações

Protagonist Therapeutics director Williams sells $1.48 million in shares

Diretor da Protagonist Therapeutics vende ações no valor de US$ 1,67 milhões

Protagonist Therapeutics director sells $1.67 million in shares

Principais ações de biotecnologia para observar em 2026, segundo a Truist

Top Biotech Stocks to Watch in 2026, According to Truist

Preço-alvo das ações da Protagonist Therapeutics elevado para US$ 117 pela H.C. Wainwright

Protagonist Therapeutics stock price target raised to $117 from $80 at H.C. Wainwright

Protagonist Stock: Assessing The 2026 Upside For Icotrokinra And Rusfertide (PTGX)